<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000745112"><TermName>FOLFIRI-cetuximab</TermName><TermPronunciation>(... seh-TUK-sih-mab)</TermPronunciation><TermDefinition><DefinitionText>A chemotherapy combination used to treat a certain type of  colorectal cancer that has spread to other parts of the body. It includes the drugs leucovorin calcium (folinic acid), fluorouracil, irinotecan hydrochloride, and cetuximab. Also called FOLFIRI-cetuximab regimen.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000746275" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;FOLFIRI-cetuximab&quot;" language="en" id="_3"/><MediaLink ref="CDR0000746274" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;FOLFIRI-cetuximab&quot;" language="es" id="_4"/><SpanishTermName>FOLFIRI-cetuximab</SpanishTermName><SpanishTermDefinition><DefinitionText>Quimioterapia combinada que se usa para tratar ciertos tipo de cáncer colorrectal que se diseminaron hacia otras partes del cuerpo. Incluye los medicamentos leucovorina cálcica (ácido folínico), clorhidrato de irinotecán y cetuximab. También se llama régimen FOLFIRI-cetuximab.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2013-01-17</DateFirstPublished></GlossaryTerm>
